Quantitative Systematic Strategies LLC Agios Pharmaceuticals, Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$44.23 - $57.5 $385,508 - $501,170	-8,716 Reduced 65.16%	4,661 $241,000
Q4 2020 Feb 09, 2021	SELL	$33.21 - $46.54 $348,040 - $487,739	-10,480 Reduced 43.93%	13,377 $580,000
Q3 2020 Nov 09, 2020	BUY	$33.87 - $55.93 $126,538 - $208,954	3,736 Added 18.57%	23,857 $835,000
Q2 2020 Aug 04, 2020	BUY	$34.45 - $53.48 $233,364 - $362,273	6,774 Added 50.75%	20,121 $1.08 Million
Q1 2020 May 06, 2020	SELL	$31.52 - $53.81 $178,466 - $304,672	-5,662 Reduced 29.79%	13,347 $474,000
Q4 2019 Feb 11, 2020	BUY	$30.08 - $50.59 $571,790 - $961,665	19,009 New	19,009 $908,000

243

58.3M

431K

309K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.82B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.